Thank you! Your request has been received.

A member of our team will reach out to you shortly,
Oops! Something went wrong while submitting the form.
+

Featured

Novartis to Acquire Avidity Biosciences for $12 Billion

Novartis AG will acquire Avidity Biosciences for USD 72.00 per share in cash, valuing the company at approximately USD 12.0 billion. Avidity will sepa...

October 27, 2025

Latest Merger & Acquisitions

Novartis to Acquire Avidity Biosciences for $12 Billion
Novartis AG will acquire Avidity Biosciences for USD 72.00 per share in cash, valuing the company at approximately USD 12.0 billion. Avidity will sepa...
October 27, 2025
Innovent and Takeda Partner to Develop Next-Gen IO and ADC Therapies
Innovent Biologics and Takeda have entered into a global strategic partnership to co-develop and commercialize Innovent's next-generation immuno-oncol...
October 22, 2025
Boehringer Ingelheim and AimedBio Collaborate to Advance Novel ADC Therapy for Broad Range of Cancers
Boehringer Ingelheim and AimedBio have entered into a global collaboration and licensing agreement to develop a novel antibody-drug conjugate (ADC) th...
October 16, 2025
Biocon Biologics and Civica Expand Partnership to Launch Insulin Glargine for U.S. Diabetes Patients
Biocon Biologics and Civica expand their partnership to include Insulin Glargine, aiming to increase the availability of affordable insulin for the 38...
October 16, 2025
Novo Nordisk to Acquire Akero Therapeutics for up to $5.2 Billion
Akero Therapeutics, a clinical-stage company focused on metabolic diseases, has entered into a definitive agreement to be acquired by Novo Nordisk for...
October 9, 2025
MaxCyte and Moonlight Bio Partner to Advance T Cell Therapies for Solid Tumors
MaxCyte and Moonlight Bio have entered into a Strategic Platform License agreement. Moonlight Bio will utilize MaxCyte’s Flow Electroporation® technol...
October 7, 2025
Elutia Closes BioEnvelope Business Sale to Boston Scientific for $88 Million, Focuses on NXT-41x for Breast Reconstruction Infections
Elutia Inc. has finalized the sale of its BioEnvelope business, including EluPro™ and CanGaroo® bioenvelopes, to Boston Scientific Corporation for $88...
October 2, 2025
Roche to Acquire 89bio for MASH Therapy Development
Roche has entered into a definitive merger agreement to acquire 89bio, Inc., a clinical-stage biopharmaceutical company, for up to $3.5 billion. The a...
September 18, 2025

Other Merger & Acquisitions

Novartis to Acquire Avidity Biosciences for $12 Billion
October 27, 2025
Innovent and Takeda Partner to Develop Next-Gen IO and ADC Therapies
October 22, 2025
Boehringer Ingelheim and AimedBio Collaborate to Advance Novel ADC Therapy for Broad Range of Cancers
October 16, 2025
Biocon Biologics and Civica Expand Partnership to Launch Insulin Glargine for U.S. Diabetes Patients
October 16, 2025
Novo Nordisk to Acquire Akero Therapeutics for up to $5.2 Billion
October 9, 2025
MaxCyte and Moonlight Bio Partner to Advance T Cell Therapies for Solid Tumors
October 7, 2025
Elutia Closes BioEnvelope Business Sale to Boston Scientific for $88 Million, Focuses on NXT-41x for Breast Reconstruction Infections
October 2, 2025
Roche to Acquire 89bio for MASH Therapy Development
September 18, 2025
Novartis Acquires Tourmaline Bio for $1.4 Billion, Expanding Cardiovascular Pipeline with Pacibekitug
September 9, 2025
Zydus and Synthon Partner for Ozanimod Capsules in the US Market
September 5, 2025
Polpharma Biologics and MS Pharma Partner to Commercialize Biosimilars in MENA
September 2, 2025
Servier and IDEAYA Biosciences Partner to Develop Darovasertib for Uveal Melanoma
September 2, 2025
LakeShore Biopharma Receives Revised Acquisition Proposal
August 29, 2025
AbbVie Acquires Gilgamesh Pharmaceuticals' Bretisilocin for Major Depressive Disorder
August 26, 2025
AbbVie Acquires Capstan Therapeutics and its Novel CAR-T Therapy Candidate
August 20, 2025
AleraCare and PURE Healthcare to Merge, Creating a Leading Ambulatory Infusion Platform
August 14, 2025
Melinta Therapeutics Acquired by CorMedix for $300 Million
August 7, 2025
CorMedix to Acquire Melinta Therapeutics, Expanding its Specialty Pharmaceutical Portfolio
August 7, 2025
Demetra Acquires OrthoFundamentals and Launches Global Spine Division
August 4, 2025
Sanofi Acquires Rights to Arrowhead's Plozasiran for Hypertriglyceridemia in Greater China
August 4, 2025
Mallinckrodt and Endo Merger Creates Global Therapeutics Leader
August 4, 2025
Hengrui Pharma and GSK Partner to Develop Up to 12 Innovative Medicines
July 28, 2025
Adaptimmune Sells Cell Therapies to US WorldMeds for $55 Million
July 28, 2025
Gate Bioscience and Lilly Partner to Develop Molecular Gate Medicines
July 25, 2025
Thermo Fisher and Sanofi Expand Partnership: Acquisition of Sterile Drug Manufacturing Site
July 17, 2025
Repare Therapeutics Outlicenses Lunresertib to Debiopharm
July 16, 2025
Cantargia Licenses CAN10 IL1RAP Immunology Program to Otsuka Pharmaceutical
July 15, 2025
Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up mRNA Manufacturing
July 10, 2025
Merck Acquires Verona Pharma for $10 Billion, Expanding COPD Treatment Portfolio
July 9, 2025
Chugai and Gero Partner to Develop Novel Therapies for Age-Related Diseases
July 8, 2025
Ligand Completes Merger with Channel Therapeutics, Launching ZELSUVMI™ for Molluscum Contagiosum
July 3, 2025
EnChannel Medical Acquires Acutus Medical's AcQMap™ Electrophysiology Assets
July 2, 2025
Biofrontera Inc. Acquires US Rights to Ameluz® and RhodoLED®, Secures $11 Million Investment
July 1, 2025
23andMe Sold to TTAM Research Institute for $305 Million
June 30, 2025
Fujirebio Acquires Plasma Services Group, Strengthening its Biomaterials Supply
June 23, 2025
RyboDyn Joins Lilly Gateway Labs to Advance Next-Gen Immunotherapies
June 19, 2025
Pierre Fabre Laboratories Acquires Worldwide Rights for PFL-721 and PFL-241, Expanding its Oncology Portfolio
June 16, 2025
Medtronic Announces MiniMed as Name for Planned New Diabetes Company
June 13, 2025
BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition
June 12, 2025
Quell Therapeutics and AstraZeneca Advance CAR-Treg Cell Therapy for Inflammatory Bowel Disease
June 10, 2025
Sanofi Acquires Vigil Neuroscience to Expand Alzheimer's Disease Pipeline
May 22, 2025
CRISPR and Sirius Therapeutics Partner to Develop siRNA Therapies for Thromboembolic Disorders
May 20, 2025
Carlyle and SK Capital Complete Acquisition of bluebird bio
May 6, 2025
Repare Therapeutics Out-Licenses Discovery Platforms to DCx Biotherapeutics
May 2, 2025

Empowering Life Sciences with
Advanced AI Solutions.

Book A Demo
HomeKnolsightsContact UsPricing
One Research Court, Suite 450, Rockville, MD 20850
info@pienomial.com
+91 9876543210
© 2025 Pienomial. All rights reserved
AboutTerms of ServicePrivacy Policy
Home/KnloSights/Mregers And Acquisitions